Log In
Print
BCIQ
Print
Print this Print this
 

CP024

  Manage Alerts
Collapse Summary General Information
Company Critical Pharmaceuticals Ltd.
DescriptionDry powder formulation of human growth hormone (hGH) formulated using CriticalSorb nasal delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I
Standard IndicationGrowth hormone deficiency
Indication DetailsTreat growth hormone deficiency (GHD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today